Subsequently, we show that the ability of this molecule to sensitise AML cells to ara‐C in a SAMHD1‐dependent manner is not through direct interaction with SAMHD1, but rather inhibition of its known target RNR. The gene discussed is NR2E3; the disease is acute myeloid leukemia.